Jeannie T Lee
- Massachusetts General Hospital · Genetics (topic-inferred)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #8,489
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1931281Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$2.3M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#8,489
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Jeannie T Lee as a PI. Multi-PI records show the full award amount for context.
- 1R01MH137056-01A1R01Contact PIR-loop-induced CGG contraction as a therapeutic approach for Fragile X syndromeMassachusetts General Hospital · Genetics (topic-inferred)$825Kaward amount
- 5R01MH118351-08R01Contact PIAdvancing an XIST ASO candidate for the treatment of Rett SyndromeMassachusetts General Hospital · Genetics (topic-inferred)$787.1Kaward amount
- 1R01HD119245-01A1R01Contact PIXist RNA and the spreading of epigenetic complexes to enact gene silencingMassachusetts General Hospital · Genetics (topic-inferred)$690.1Kaward amount
Award organization
Organizations that administered FY2026 awards listing Jeannie T Lee as a PI.
FY2026 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9051
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding